These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3681386)

  • 1. PCNU and recurrent childhood brain tumors.
    Allen JC; Hancock C; Walker R; Tan C
    J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of intracarotid PCNU.
    Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
    J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
    J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
    Ragab AH; Burger P; Badnitsky S; Krischer J; Van Eys J
    J Neurooncol; 1986; 3(4):341-2. PubMed ID: 3958779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNU: phase II evaluation in advanced colorectal carcinoma.
    Pazdur R; Samson MK; Baker LH
    Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
    Malkin MG; Green SB; Byar DP; Strike TA; Burger PC; Vogel FS; Pistenmaa DA; Mahaley MS; Ransohoff J; Shapiro WR
    J Neurooncol; 1994; 22(1):55-65. PubMed ID: 7714551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.
    Hiesiger EM; Green SB; Shapiro WR; Burger PC; Selker RG; Mahaley MS; Ransohoff J; VanGilder JC; Mealey J; Robertson JT
    J Neurooncol; 1995; 25(2):143-54. PubMed ID: 8543970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Muggia FM; Golomb FM
    Invest New Drugs; 1985; 3(3):297-301. PubMed ID: 4066223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas.
    Feun LG; Maor M; Stewart DJ; Leavens ME; Savaraj N; Bodey GP
    Oncology; 1990; 47(5):389-92. PubMed ID: 2170890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases.
    Feldman LD; Feun LG; Benjamin RS; Yap BS; Plager C; Papadopoulos N; Savaraj N; Burgess MA; Bodey GP
    Am J Clin Oncol; 1985 Jun; 8(3):215-7. PubMed ID: 4050740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of PCNU in children with recurrent brain tumors and Hodgkin's disease.
    Hancock C; Allen J; Tan CT
    Cancer Treat Rep; 1984 Feb; 68(2):441-2. PubMed ID: 6321022
    [No Abstract]   [Full Text] [Related]  

  • 14. PCNU treatment for recurrent malignant gliomas.
    Levin VA; Resser KJ; McGrath L; Vestnys P; Nutik S; Wilson CB
    Cancer Treat Rep; 1984; 68(7-8):969-73. PubMed ID: 6744348
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I trial of PCNU administered by 5-day courses.
    Earhart RH; Koeller JM; Davis HL
    Cancer Treat Rep; 1981; 65(9-10):835-40. PubMed ID: 7273016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCNU: a new nitrosourea in clinical oncology.
    Poster DS; Penta JS; Bruno S
    Am J Clin Oncol; 1982 Feb; 5(1):9-12. PubMed ID: 7081143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
    J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.